Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Clinical trial NCT00411242 · COMPLETED

Trial details

NCT number: NCT00411242
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2006-12-01
Primary completion: 2008-01-01
Enrollment: 503

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.